• Skip to navigation
  • Skip to content

Responding to COVID-19.    Read More

 
  • HELP
    • Send Email to Wow! Customer Care
    • Contact Us
    • FAQ
  • PARTNERSHIP
    • Partner with FFF Enterprises
    • Manufacturing Partners
  • ORDER
  • Be Prepared
    • Symptoms & Treatment
    • Plan Your Flu Clinics
    • Reference Charts
    • Flu Prevention Posters
    • Flu Myths & Facts Brochures
  • Vaccines
    • Product Portfolio
    • Manufacturing Partners
  • Awareness
    • News
    • Subscribe to Flu Updates
    • Flu Activity
    • Flu Information
    • History
  • Other Services
    • Lot-Track
    • BioSupply
  • About MFV
    • About MyFluVaccine
    • Guaranteed Channel Integrity
    • Testimonials
    • FAQ
800.843.7477, FFF Enterprises
  • Home/
  • About MFV/
  • News/
  • Article

WHO Recommends One Strain Change for 2016-17 Flu Vaccine

Date: February 25, 2016

The World Health Organization (WHO) recommends changing one strain, for the Northern Hemisphere's 2016-17 flu season, and changing the order of the B strains, based on its advisory group's in-depth analysis of the most recent circulating viruses. Read more

An A/Hong Kong H3N2 associated with outbreaks in some countries, was recommended to replace this season's A/Switzerland/9715293/2013, and it was recommended that B/Brisbane/60/2008, change positions with last season’s B/Phuket strain in the trivalent vaccines. For the quadrivalent vaccines, the B/Phuket strain was recommended as the 2nd B strain.

The WHO recommends that trivalent vaccines for use in the 2016-17 influenza season (Northern Hemisphere winter) contain the following:

  • An A/California/7/2009 (H1N1)pdm09-like virus;
  • An A/Hong Kong/4801/2014 (H3N2)-like virus;
  • A B/Brisbane/60/2008-like virus.

The WHO also recommends that quadrivalent vaccines containing two influenza B viruses contain the above three viruses and a B/Phuket/3073/2013-like virus.

For more information and to read the complete report, visit — www.who.int/influenza/vaccines/virus/recommendations/201602_recommendation.pdf?ua=1

This recommendation by the WHO will be reviewed by the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) on March 4th and a final decision on the 2016-17 influenza vaccine strains will be decided at that time. It is often common that the VRBPAC panel follows the recommendations of the WHO.

The final VRBPAC decision allows vaccine manufacturers to start formulating the upcoming seasonal flu vaccine, a process that takes about 6 months.

Be Prepared This Flu Season
Place your 2016-17 influenza vaccine orders through MyFluVaccine with preferred pricing for early orders today! Visit MyFluVaccine or call your FFF representative or Wow! Customer Care at (800) 843-7477, to select from our comprehensive influenza vaccines portfolio and delivery date(s) that work best for you.

  • News
  • Subscribe to Flu Updates
  • Flu Activity
  • Flu Information
  • History

800.843.7477

Contact Wow! Customer Care
Expanded Product Portfolio
Order Now
FFF Enterprises, Inc.
44000 Winchester Road
Temecula, CA 92590
P: 800.843.7477, 951.296.2500
F: 800.418.4333

Terms of Use | Terms of Sale | Privacy Statement |
© FFF Enterprises, Inc.  -   Home | About MFV | Flu Vaccines | Flu Myths & Facts | Subscribe to Flu Updates

Top